You can help support the Alzamend Neuro mission and participate in the company as an equity shareholder too. For as little as $100.00 you can participate as an owner. Alzamend Neuro in December 8, 2016 was qualified by the SEC to raise $50,000,000 dollars using the Reg A+ exemption. This allows the company to accept investment from all types of investors, including accredited, non-accredited and institutional. The company will soon pursue to raise capital using the Reg. A+ Tier II exemption.
Please sign up to be notified when the next investment opportunity is available:
For general questions:
Your email address has been added to our mailing list